lin-12 belongs to a large family of transmembrane receptor proteins including
glp-1 in C. elegans, Notch in Drosophila, and TAN-1,
int-3 of mammals. All members of the
lin-12/Notch family have multiple EGF repeats in their extracellular domains and
cdc10/SWI6 (ankyrin) repeats in their intracellular domains. There is also evidence that
lin-12/Notch proteins share conserved ligands and effectors. Given that the
cdc10/SWI6 repeats are known to be involved in protein-protein interactions, it is likely that the
cdc10/SWI6 repeats of
lin-12 and
glp-1 mediate interaction with downstream effectors. We have used the yeast two hybrid system and screened a miniature fusion library made by our lab and a comprehensive fusion library made by Dr. Robert Barstead. In the process of making GAL-4 DNA binding fusion constructs, we found that the intact intracellular domain of
lin-12 has the activation activity. By truncating the C terminal portion of
lin-12 intracellular domain, leaving the
cdc10/SWI6 repeats intact, we were able to make a construct without activation activity. We also made an equivalent construct of the
glp-1 intracellular domain. By selecting their ability to grow on 3-AT plate (His+ selection) and their ability to turn blue on beta-gal filter assay when the
lin-12 bait was presented, we were able to identify 51 potential candidates. Judging by their ability to interact with both
lin-12 and
glp-1 intracellular domain baits, the strength of the interaction on filter assay and partial sequencing analysis, we were able to narrow this group down to 13 candidates. We have mapped all the candidates and are doing sequence analysis on all of the inserts. Based on their map position, we are also using genomic phage clones from the genes found in our screen in transformation rescue experiments. Out of the 13 candidates, two correspond to known genes,
emb-5 and
skn-1. We are examining existing
emb-5 and
skn-1 mutants for phenotypes associated with mutations in
lin-12 or
glp-1, and examining the phenotypes of various double mutants for genetic interactions. We will report our progress at the meeting (see also the abstract of Hubbard & Greenwald).